BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Otani K, Chijiiwa K, Kai M, Ohuchida J, Nagano M, Tsuchiya K, Kondo K. Outcome of surgical treatment of hilar cholangiocarcinoma. J Gastrointest Surg. 2008;12:1033-1040. [PMID: 18085342 DOI: 10.1007/s11605-007-0453-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Lee TH, Moon JH, Park SH. Bilateral metallic stenting in malignant hilar obstruction. Clin Endosc. 2014;47:440-446. [PMID: 25325005 DOI: 10.5946/ce.2014.47.5.440] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
2 Noji T, Tsuchikawa T, Ebihara Y, Nakamura T, Kato K, Matsumoto J, Tanaka E, Shichinohe T, Hirano S. Post-operative depletion of platelet count is associated with anastomotic insufficiency following intrahepatic cholangiojejunostomy: a case-control study from the results of 220 cases of intrahepatic cholangiojejunostomy. BMC Surg 2014;14:81. [PMID: 25323783 DOI: 10.1186/1471-2482-14-81] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Bokemeyer A, Matern P, Bettenworth D, Cordes F, Nowacki TM, Heinzow H, Kabar I, Schmidt H, Ullerich H, Lenze F. Endoscopic Radiofrequency Ablation Prolongs Survival of Patients with Unresectable Hilar Cholangiocellular Carcinoma - A Case-Control Study.Sci Rep. 2019;9:13685. [PMID: 31548703 DOI: 10.1038/s41598-019-50132-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
4 Liu F, Hu HJ, Ma WJ, Wang JK, Ran CD, Regmi P, Li FY. Is radical resection of hilar cholangiocarcinoma plus partial resection of pancreatic head justified for advanced hilar cholangiocarcinoma? ANZ J Surg. 2020;90:1666-1670. [PMID: 32452116 DOI: 10.1111/ans.15955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tarantino L, Busto G, Nasto A, Nasto RA, Tarantino P, Fristachi R, Cacace L, Bortone S. Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: A feasibility study. Eur J Surg Oncol. 2018;44:1603-1609. [PMID: 30017329 DOI: 10.1016/j.ejso.2018.06.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
6 Shi Z, Yang MZ, He QL, Ou RW, Chen YT. Addition of hepatectomy decreases liver recurrence and leads to long survival in hilar cholangiocarcinoma. World J Gastroenterol 2009; 15(15): 1892-1896 [PMID: 19370789 DOI: 10.3748/wjg.15.1892] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
7 Chauhan A, House MG, Pitt HA, Nakeeb A, Howard TJ, Zyromski NJ, Schmidt CM, Ball CG, Lillemoe KD. Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma. HPB (Oxford). 2011;13:139-147. [PMID: 21241432 DOI: 10.1111/j.1477-2574.2010.00262.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
8 Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, Khor CJ, Ponnudurai R, Moon JH, Seo DW, Pantongrag-Brown L, Sangchan A, Pisespongsa P, Akaraviputh T, Reddy ND, Maydeo A, Itoi T, Pausawasdi N, Punamiya S, Attasaranya S, Devereaux B, Ramchandani M, Goh KL; Asia-Pacific Working Group on Hepatobiliary Cancers. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2013;28:593-607. [PMID: 23350673 DOI: 10.1111/jgh.12128] [Cited by in Crossref: 135] [Cited by in F6Publishing: 113] [Article Influence: 16.9] [Reference Citation Analysis]
9 Abd ElWahab M, El Nakeeb A, El Hanafy E, Sultan AM, Elghawalby A, Askr W, Ali M, Abd El Gawad M, Salah T. Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World J Gastrointest Surg 2016; 8(6): 436-443 [PMID: 27358676 DOI: 10.4240/wjgs.v8.i6.436] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
10 Unno M, Katayose Y, Rikiyama T, Yoshida H, Yamamoto K, Morikawa T, Hayashi H, Motoi F, Egawa S. Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2010;17:463-469. [PMID: 19941010 DOI: 10.1007/s00534-009-0206-3] [Cited by in Crossref: 69] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
11 Goenka MK, Goenka U. Palliation: Hilar cholangiocarcinoma. World J Hepatol 2014; 6(8): 559-569 [PMID: 25232449 DOI: 10.4254/wjh.v6.i8.559] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
12 Liu F, Hu H, Regmi P, Li F. Hilar cholangiocarcinoma with distal bile duct involvement: Is hepatopancreatoduodenectomy always required? Clinics and Research in Hepatology and Gastroenterology 2018;42:610-1. [DOI: 10.1016/j.clinre.2018.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Schlitter AM, Esposito I. Definition of microscopic tumor clearance (r0) in pancreatic cancer resections. Cancers (Basel). 2010;2:2001-2010. [PMID: 24281214 DOI: 10.3390/cancers2042001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
14 Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014;399:693-705. [PMID: 24841192 DOI: 10.1007/s00423-014-1210-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
15 Zhu YZ, Zhou K, Ruan LL, Sun F, Wang G, Li WF. Metadherin overexpression in perihilar cholangiocarcinoma is associated with lymph node metastasis and poor prognosis. Oncol Lett 2019;17:4514-20. [PMID: 30988817 DOI: 10.3892/ol.2019.10141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Kobayashi S, Nagano H, Hoshino H, Wada H, Marubashi S, Eguchi H, Takeda Y, Tanemura M, Kim T, Shimosegawa E, Hatazawa J, Doki Y, Mori M. Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer: FDG-PET in Biliary Cancer. J Surg Oncol 2011;103:223-9. [DOI: 10.1002/jso.21811] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
17 Endo I, House MG, Klimstra DS, Gönen M, D'Angelica M, Dematteo RP, Fong Y, Blumgart LH, Jarnagin WR. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Ann Surg Oncol 2008;15:2104-12. [PMID: 18543039 DOI: 10.1245/s10434-008-0003-2] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 6.2] [Reference Citation Analysis]
18 Ota Y, Matsuyama R, Taniguchi K, Ueda M, Takeda K, Tanaka K, Nakayama T, Endo I. Solitary rib recurrence of hilar cholangiocarcinoma 10 years after resection: report of a case. Clin J Gastroenterol 2013;6:485-9. [PMID: 24319501 DOI: 10.1007/s12328-013-0432-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
19 Iso Y, Kita J, Kato M, Shimoda M, Kubota K. When hepatic-side ductal margin is positive in N+ cases, additional resection of the bile duct is not necessary to render the negative hepatic-side ductal margin during surgery for extrahepatic distal bile duct carcinoma. Med Sci Monit 2014;20:471-5. [PMID: 24657986 DOI: 10.12659/MSM.889714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
20 Lee SJ, Kwon W, Kang MJ, Jang JY, Chang YR, Jung W, Kim SW. Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma. Korean J Hepatobiliary Pancreat Surg 2014;18:1-8. [PMID: 26155239 DOI: 10.14701/kjhbps.2014.18.1.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Fang Z, Lu L, Tian Z, Luo K. Overexpression of phosphorylated 4E-binding protein 1 predicts lymph node metastasis and poor prognosis of Chinese patients with hilar cholangiocarcinoma. Med Oncol 2014;31:940. [PMID: 24706262 DOI: 10.1007/s12032-014-0940-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
22 Wang F, Liu Y, Zhang H. Loss of MTSS1 Expression is an Independent Prognostic Factor for Hilar Cholangiocarcinoma. Pathol Oncol Res 2013;19:815-20. [DOI: 10.1007/s12253-013-9649-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
23 Zhang Z, Xing H, Yuan H, Liu K, Zhu J, Su Y, Guo J, Jiang N, Zhang Z. Diagnosis and treatment for advanced hilar cholangiocarcinoma: experience of 24 cases. Front Med China 2008;2:134-8. [DOI: 10.1007/s11684-008-0025-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]